Table 2 Participant demographics, baseline clinical characteristics and pre-existing cardiovascular risk factors (Medical Record Review cohort only)
From: Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
|  | N = 46 n (%) |
|---|---|
Demographics | |
 Female | 23 (50) |
 Married/de facto | 28 (61) |
 Country of birth (Australia) | 32 (70) |
 Private health insurance | 15 (33) |
 Mean age of cardiotoxicity diagnosis (years) | 58.5 |
Baseline clinical characteristics (pre-existing risk factors) | |
 ≥ 1 risk factor | 41 (90) |
 ≥ 4 risk factors | 11 (24) |
 Diabetes (type 1 or 2) | 12 (26) |
 Hypertension | 22 (48) |
 Hypercholesterolemia | 14 (30) |
 Stroke | 1 (2) |
 Angina | 5 (11) |
 Arrhythmia (atrial fibrillation) | 6 (13) |
 Valvular disease | 1 (2) |
 Current−/ex-smoker | 19 (41) |
 Social drinker | 11 (24) |
 Overweight/obese | 18 (39) |
 Family history of cardiovascular disease | 11 (24) |
 Participants with four or more risk factors | 11 (24) |